We found that high expression of SLC7A11, GPX4, and AIFM2 were significantly linked with the shortened disease-free survival in adrenocortical carcinoma (ACC), respectively, and high expression of SLC7A11 and AIFM2 were significantly associated with shortened OS in ACC respectively (Figures 3A–I). Here, AIFM2 is linked to adrenal cortex carcinoma.